Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Aspirin × Other × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 38 Breast 10 Myeloid 8 Genitourinary 8 Plasma cell 6 Gynecologic 6 Classical hematology 6 Tumor-Agnostic 4 Thoracic 4 Head & Neck 4 Other neoplasm 3 Sarcoma 2 Other hematologic neoplasm 2 Dermatologic 2 CNS 2 Other solid neoplasm 1 Other 1 Lymphoid 1

Conditions

Interventions

Exercise 23 Metformin 19 Methods 12 Early Intervention, Educational 11 Standard of Care 10 Radiotherapy 10 Educational Status 10 Counseling 9 Surveys and Questionnaires 7 Nutrition Assessment 7 Diet Therapy 7 Diet 7 naloxegol 6 Tirzepatide 6 Caloric Restriction 6 alvimopan 5 Resistance Training 5 Radiation 5 Psychiatric Rehabilitation 5 Exenatide 5 Dexamethasone 5 Cisplatin 5 Specimen Handling 4 Mouthwashes 4 Morphine 4 Liraglutide 4 Lidocaine 4 Interviews as Topic 4 Injections 4 Fibroblast Growth Factor 7 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02062255 2016-10-26

Impact of COX2 on Sera Biomarkers From Obese Subjects

The University of Texas Health Science Center at San Antonio

Phase EARLY_PHASE1 Completed

Obesity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡